American Scientific Resources Inc. (ASFX) Financials Nov

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
American Scientific Resources Inc. (ASFX) Financials Nov 13, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for American Scientific Resources Inc.


Fiscal year is January-December. All values USD millions. 2006 2007 2008 2009 2010 5-year trend
Sales/Revenue 303,786 269,970 910,577 734,495 862,369
Cost of Goods Sold (COGS) incl. D&A 172,238 158,775 472,565 368,524 754,902
COGS excluding D&A 150,606 137,143 471,425 315,830 540,851
Depreciation & Amortization Expense 21,632 21,632 1,140 52,694 214,051
Depreciation - - - - -
Amortization of Intangibles - - - - -
Gross Income 131,548 111,195 438,012 365,971 107,467
2006 2007 2008 2009 2010 5-year trend
SG&A Expense 3.97M 2.75M 5.2M 2.09M 3.29M
Research & Development 0 0 0 0 0
Other SG&A 3.97M 2.75M 5.2M 2.09M 3.29M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 219,904 37,421 (33,311) 1.61M
EBIT after Unusual Expense 0 (219,904) (37,421) 33,311 (1.61M)
Non Operating Income/Expense 133,748 (5,182) (13,078) (88,380) (49,990)
Non-Operating Interest Income - - - - -
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 11,373 485,281 1.59M 656,450 2.2M
Gross Interest Expense 11,373 485,281 1.59M 656,450 2.2M
Interest Capitalized 0 0 0 0 0
Pretax Income (3.72M) (3.34M) (6.41M) (2.44M) (7.04M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 0 0
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic 0 0 0 0 0
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (3.72M) (3.34M) (6.41M) (2.44M) (7.04M)
Minority Interest Expense 0 0 0 0 0
Net Income (3.72M) (3.34M) (6.41M) (2.44M) (7.04M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (3.72M) (3.34M) (6.41M) (2.44M) (7.04M)
Preferred Dividends 0 0 0 985,000 0
Net Income Available to Common (3.72M) (3.34M) (6.41M) (3.42M) (7.04M)
EPS (Basic) (58.00) (32.00) (8.00) () (0.01)
Basic Shares Outstanding 65,241 105,235 733,076 6.04M 9.85M
EPS (Diluted) (58.00) (32.00) (8.00) () (0.01)
Diluted Shares Outstanding 65,241 105,235 733,076 6.04M 9.85M
EBITDA (3.82M) (2.61M) (4.76M) (1.68M) (2.97M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AULUMU Unveils High-Design ADuo iPhone Case

Updated Category News Views 7

A Space-Aged Look for Everyday Use In the gadget world, appearances matter but durability matters more. So AULUMU rolls out the ADuo Particle Aramid Fiber Case for iPhone Duo, making a bold claim in the realm of tech accessories. The Backbone: Aramid Fiber Aramid fiber isn't your run-of-the-mill material. We're talking 1500D quality here—strong but feather-light, a...

Continue Reading
Qatar's Cultural Ventures Go Big Through 2030

Updated Category News Views 2

Cultural Partners Lined Up Well Ahead In the swirling world of cultural diplomacy, Qatar's got its eyes set way beyond the skyline with their Years of Culture initiative. Announced recently, they've lined up partners through 2030, locking hands with Italy, the Netherlands, Switzerland, Portugal, and Spain in the coming years. Such moves aren't just for show—they’re...

Continue Reading
TORL Bio's Ixo-V Drug Shows Promise in Combatting GCT

Updated Category News Views 4

A Beacon of Hope in Germ Cell Tumor Treatment There's something brewing in the oncology world that's worth a nod. TORL BioTherapeutics has rolled out some interesting preliminary data for their hopeful cancer buster, ixotatug vedotin, or Ixo-V. This study is part of a wider effort to take a swing at recurrent germ cell tumors (GCTs) with some tough results already making...

Continue Reading
GoDaddy Launches 'Ink Your Link' in NYC

Updated Category News Views 5

GoDaddy's Bold Stunt at the Big Apple In the noise of the New York Stock Exchange, everyone is abuzz with GoDaddy’s latest marketing push. Aptly titled 'Ink Your Link,' this campaign has NYC in its sights this weekend, targeting entrepreneurs and consumers alike. The plan is to open a unique pop-up in Manhattan where business owners can ink a temporary tattoo—a bold...

Continue Reading
SOCaaS Market Grows to $16.68B by 2031, What It Means

Updated Category News Views 9

SOC as a Service: More Than Just Jargon The term 'SOC as a Service' (SOCaaS) might sound like some alphabet soup, but it’s a serious contender in today’s digital security world. With projected growth from $9.04 billion in 2026 to a whopping $16.68 billion by 2031, the SOCaaS market isn’t just having a moment, it’s setting up a stage for the long haul. It’s like...

Continue Reading
Hyperliquid Expands Stock Buyback to $100 Million

Updated Category News Views 0

Diving Into Hyperliquid's $100 Million Bold Move Let’s cut through the corporate fluff—Hyperliquid Strategies Inc. just cranked up their stock repurchase program to a cool $100 million. Yep, that’s right—the brain trust behind NASDAQ:PURR has pulled out the checkbook to buy more of its own shares. This decision, unveiled on October 23, 2026, is like tossing a...

Continue Reading
Autoliv Sees Mixed Q3 2026 Amid Global Challenges

Updated Category News Views 4

An Uneven Road: Autoliv's Q3 2026 Chronicle You'd think by now everyone in the automotive game would have mastered the art of the pivot. Well, Autoliv seems to have gotten the memo for Q3 2026. Sales dipped slightly, yet their moves in Asia hint at a calculated gambit in a rough global landscape. Digging into the Numbers The financials were a mixed bag. Net sales huddled...

Continue Reading
Tragedy in Jordan: A Call for Unity and Support

Updated Category News Views 0

A Dark Day in Jordan It's a gut punch, hearing news of yet another brutal attack targeting the Christian community in Jordan's Karak province. This act of terror isn't just a regional dagger—it cuts deep into the fabric of shared humanity. On Friday, the tranquil air of a sacred gathering was shattered, leaving behind grief and a call to action for those who refuse to...

Continue Reading
Ractigen's LiCO™ Platform Hits Extrahepatic Milestones

Updated Category News Views 5

Breaking New Ground in RNA Therapeutics Hey, in the world of biotech, landing a meaningful delivery system is like striking gold, and it seems Ractigen Therapeutics just found a shiny nugget. Their latest study on the LiCO™ platform, living and breathing in the pages of Molecular Therapy - Nucleic Acids, maps out a path to some serious therapeutic territory. These guys...

Continue Reading
Savvy Moves: Avoiding Pitfalls When Buying Used Vans

Updated Category News Views 4

When you're eyeing a used work van, don't just kick the tires and jot down the mileage—there's a whole backyard BBQ checklist you need to chew through. Tony Collichio, the work van guru from Spencerport, lays it down for us, highlighting key questions to ask before pulling out the checkbook. And let me tell you, these aren’t your everyday 'how does it drive?' queries....

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Blackbaud's Short Interest Trends and Market Sentiment

Updated Category News Views 254

Understanding Blackbaud's Short Interest Dynamics Blackbaud's short interest, which refers to stocks that are sold short but not yet repurchased, has seen a notable decrease of 6.58% according to the latest report. This decline is intriguing given its critical role in investment strategies. Currently, the company has 613,000 shares sold short, making up approximately...

Continue Reading
ECARX Reports Strong Financial Performance for 2024

Updated Category News Views 180

ECARX Holdings Inc. Overview ECARX Holdings Inc. (NASDAQ: ECX), a pioneering global mobility technology provider, recently published its unaudited financial results for 2024. The year marked a remarkable journey for the company, demonstrating considerable growth and strategic advancement in the automotive technology sector. Highlights of 2024 Financial Performance Strong...

Continue Reading
Emerging Cancer Treatment Innovations Transform Patient Care

Updated Category News Views 282

Innovative Approaches in Cancer Treatment The landscape of cancer treatment is rapidly evolving, with breakthroughs that are reshaping how we approach various forms of this complex disease. Major pharmaceutical companies are making waves with new survival data and innovative lung cancer treatments that leverage distinct mechanisms. These advancements represent a shift in...

Continue Reading
Peter Schiff Raises Concerns Over MicroStrategy's Debt Moves

Updated Category News Views 285

Peter Schiff Questions MicroStrategy's Financial Strategy Economist and market analyst Peter Schiff recently expressed doubts regarding MicroStrategy Inc’s MSTR approach to convertible debt offerings. His comments raise alarms about possible financial instability, especially for companies heavily invested in Bitcoin. Recent Market Behavior Despite a 2.5% rise in...

Continue Reading
Strategic Expansion: Harbor Group International's Latest Acquisition

Updated Category News Views 235

Harbor Group International's Commitment to Growth Harbor Group International, LLC (HGI), a dedicated real estate investment and management firm, has made a significant move in their strategy by acquiring Reflections, a multifaceted community that adds substantial value to their existing portfolio. A Strategic Acquisition HGI has successfully completed an acquisition...

Continue Reading